Which of the following are treatment options for antipsychotic-induced weight gain?

Which of the following are treatment options for antipsychotic-induced weight gain?

• A. Healthy lifestyle, switching agents, weight loss meds
• B. Increase antipsychotic dose
• C. Time off treatment
• D. Hospitalization

Answer: (D)

Managing antipsychotic-induced weight gain relies on a multipronged approach: lifestyle changes, adjustments to the medication regimen, and, when needed, weight-focused pharmacotherapy. Start with healthy lifestyle measures—balanced diet, regular physical activity, sleep hygiene, and ongoing monitoring of weight, BMI, waist circumference, glucose, and lipids. If weight gain remains a problem, consider switching to an antipsychotic with a lower metabolic risk (for example, aripiprazol­e, ziprasidone, or lurasidone) to reduce further weight gain while maintaining symptom control. If weight gain persists despite a switch, adding medications that help with weight management, such as metformin or, in some cases, GLP-1 receptor agonists, can be considered along with continued lifestyle support. Increasing the antipsychotic dose tends to worsen weight gain and metabolic issues, and stopping treatment or hospitalization isn’t a targeted strategy for weight management, as it risks relapse of psychosis.

Managing antipsychotic-induced weight gain relies on a multipronged approach: lifestyle changes, adjustments to the medication regimen, and, when needed, weight-focused pharmacotherapy. Start with healthy lifestyle measures—balanced diet, regular physical activity, sleep hygiene, and ongoing monitoring of weight, BMI, waist circumference, glucose, and lipids. If weight gain remains a problem, consider switching to an antipsychotic with a lower metabolic risk (for example, aripiprazol­e, ziprasidone, or lurasidone) to reduce further weight gain while maintaining symptom control. If weight gain persists despite a switch, adding medications that help with weight management, such as metformin or, in some cases, GLP-1 receptor agonists, can be considered along with continued lifestyle support. Increasing the antipsychotic dose tends to worsen weight gain and metabolic issues, and stopping treatment or hospitalization isn’t a targeted strategy for weight management, as it risks relapse of psychosis.